Literature DB >> 32123989

The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges.

Sheng Zhang1, Meng Yuan Diao2, Liwei Duan3, Zhaofen Lin4, Dechang Chen5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32123989      PMCID: PMC7079863          DOI: 10.1007/s00134-020-05977-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
Dear Editor, Since December 2019, an outbreak of novel coronavirus (SARS-CoV-2) that began from Wuhan, Hubei Province, has rapidly spread to 34 provincial-level divisions of China [1] and 25 countries around the world [2]. Up to February 15, 2020, 68,586 cases in China and 526 cases in other countries have been identified as having COVID-19 (eFigure 1). The estimated mortality rate is 3.1% in Wuhan, 2.8% in Hubei Province, 0.6% in other provinces of China, 2.4% in China and 0.4% in other countries, respectively. Faced with such a grim situation, the Chinese government has taken a series of unprecedented rigorous measures. First, all the 31 provincial-level divisions in China mainland have launched the highest level of responding mechanism for major public health emergency. Second, Wuhan and other 12 cities in Hubei Province have consecutively shut down all outbound transportation channels and suspended public transportation. Third, the State Council announced that both the Spring Festival holiday and winter vacation will be extended. Fourth, two emergency makeshift hospitals (Huoshenshan and Leishenshan hospitals) with a total capacity of 2600 beds were built and more than ten cabin hospitals were renovated with more than 10,000 beds in Wuhan. Fifth, more than 30,000 members from military and public hospitals have successively headed out to Wuhan and other cities in Hubei Province. Although the number of confirmed cases is still increasing, the increasing rate has showed a downward trend from February 4, 2020 (eFigure 2). Despite Hubei Province, Guangdong, Henan, Zhejiang, Hunan and Anhui are the top five provinces with respect to the ranking order of confirmed cases. The increasing rates of confirmed cases in these provinces also showed a downward trend recently (eFigure 3). Using a real-time Bayesian estimation model and a reported serial interval of COVID-19 [3, 4], we computed time-dependent reproduction number, R(t), which is defined as the expected number of secondary cases that one primary case will generate during infectious disease transmission. As shown in Fig. 1, R(t) has showed a downward trend in Wuhan, Hubei Province, outside Hubei, and China from January 27, 2020, to February 10, 2020. The downward trend of R(t) indicates that the prevention and control measures may be effective, although long-term effects remain to be evaluated.
Fig. 1

Real-time reproduction number of COVID-19 in China, outside Hubei, Hubei and Wuhan. Real-time reproduction number R(t) with 95% confidence interval of COVID-19 in a China, b outside Hubei, c Hubei Province and d Wuhan. The estimates of R(t) were truncated at February 10, 2020, because the diagnosis criteria for COVID-19 are adjusted since February 12, giving a sharp increase in number of new cases who was identified as having COVID-19. Incorporating these data for R(t) derivation would obtain misleading results

Real-time reproduction number of COVID-19 in China, outside Hubei, Hubei and Wuhan. Real-time reproduction number R(t) with 95% confidence interval of COVID-19 in a China, b outside Hubei, c Hubei Province and d Wuhan. The estimates of R(t) were truncated at February 10, 2020, because the diagnosis criteria for COVID-19 are adjusted since February 12, giving a sharp increase in number of new cases who was identified as having COVID-19. Incorporating these data for R(t) derivation would obtain misleading results However, we still confront a number of great challenges. First, source of SARS-CoV-2 remains pendent and the population is generally susceptible to the new virus. Second, although human-to-human spread [3] is thought to occur mainly via respiratory droplets and close contact, fecal–oral transmission or vertical transmission may also be a means of transmission. Third, asymptomatic cases with COVID-19 have been reported [5], and several places in China have reported confirmed cases without clear transmission chain, which indicates that there may be some infected cases still wandering among population and spreading virus. Fourth, as the Spring Festival holiday nears its end, hundreds of millions people will migrate from hometown to metropolitan areas for work. Such a large scale of population migration proposes a huge challenge for epidemic control and prevention. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 498 kb)
  3 in total

1.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

2.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

3.  Real time bayesian estimation of the epidemic potential of emerging infectious diseases.

Authors:  Luís M A Bettencourt; Ruy M Ribeiro
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

  3 in total
  12 in total

1.  The fading impact of lockdowns: A data analysis of the effectiveness of Covid-19 travel restrictions during different pandemic phases.

Authors:  Barry Smyth
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

Review 2.  SARS, MERS and COVID-19 among healthcare workers: A narrative review.

Authors:  Jian Xiao; Min Fang; Qiong Chen; Bixiu He
Journal:  J Infect Public Health       Date:  2020-05-27       Impact factor: 3.718

3.  SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital.

Authors:  Jie Wang; Haiting Feng; Sheng Zhang; Zuowei Ni; Lingmei Ni; Yu Chen; Lixin Zhuo; Zifeng Zhong; Tingting Qu
Journal:  Int J Infect Dis       Date:  2020-04-18       Impact factor: 3.623

4.  Students Supporting Critical Care - A contention plan to prevent the decompensation of ICUs in the COVID-19 pandemic:Translating Bjorn Ibsens' polio-lessons to modern times.

Authors:  Pedro David Wendel Garcia; Paola Massarotto; Katja Auinger; Reto Andreas Schuepbach; Stephanie Klinzing
Journal:  Crit Care       Date:  2020-05-08       Impact factor: 9.097

Review 5.  Probiotics in the prophylaxis of COVID-19: something is better than nothing.

Authors:  Kushal Gohil; Rachel Samson; Syed Dastager; Mahesh Dharne
Journal:  3 Biotech       Date:  2020-11-26       Impact factor: 2.406

6.  Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study.

Authors:  Luoning Gou; Ming Xiang; Xiao Ran; Fen Wang; Shujun Zhang; Shusheng Li; Kun Dong; Xi Chen; Yangxin Huang; Chengzhen Meng; Qian Fan; Yan Yang; Xuefeng Yu; Delin Ma; Ping Yin
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-07       Impact factor: 3.168

7.  [SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate].

Authors:  T Finkenzeller; A Faltlhauser; K-H Dietl; C Paetzel; N Szczypien; F Klawonn; K-F Bodmann; A von Meyer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-12-03       Impact factor: 0.840

8.  Establishing a standardized FUO emergency department: design and practice in dealing with COVID-19.

Authors:  Tongtong Chen; Xudong Ma; Shuai Zhou; Hanqi Wang; Yaling Pan; Liuping Chen; Haiying Lv; Yong Lu
Journal:  Ann Transl Med       Date:  2020-06

9.  Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.

Authors:  Hyun-Sook Kim; Myeung-Su Lee; HyungJin Kim; Yoon-Kyoung Sung; Jisoo Lee; Seung-Cheol Shim; Sung-Hwan Park; Han Joo Baek
Journal:  Rheumatol Int       Date:  2020-06-02       Impact factor: 2.631

10.  A Tempo-geographic Analysis of Global COVID-19 Epidemic Outside of China.

Authors:  Huipeng Liao; Gifty Marley; Yafei Si; Zaisheng Wang; Yewei Xie; Cheng Wang; Weiming Tang
Journal:  medRxiv       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.